PECAM-1 Antibodies

Platelet endothelial cell adhesion molecule-1 (PECAM-1 or CD31) has a molecular weight of approximately 130 kDa. It is primarily expressed on the surface of endothelial cells, which line blood vessels, and is also found on platelets, leukocytes, and some hematopoietic cells. It plays a key role in cell adhesion, particularly in the interaction between endothelial cells. It is also involved in regulating leukocyte migration, angiogenesis, and the maintenance of vascular integrity.

PECAM-1 has been implicated in various diseases, including inflammatory disorders and cardiovascular diseases. Inflammatory conditions involve increased expression and activation of platelet endothelial cell adhesion molecule-1 to facilitate leukocyte extravasation and tissue infiltration.

Antibodies against PECAM-1 are commonly used in research to study its expression and localization in tissues. They are employed in immunohistochemistry and flow cytometry to analyze the presence of PECAM-1 on cell surfaces. Notably, its expression patterns can be used diagnostically, as changes in its expression may be associated with vascular or inflammatory diseases.

Synonyms

Platelet endothelial cell adhesion molecule, CD31|CD31/EndoCAM|GPIIA'|PECA1|PECAM-1|endoCAM

Research Areas

Apoptosis, Autophagy, Breast Cancer, Cancer, Cardiovascular, Cell Biology, Cellular Markers and Tags, Developmental Biology, Endocrine, Epigenetics, Gastrointestinal Tract, Hypoxia, Immuno Oncology, Immunology, Kidney, Lymphatic, Metabolism, Microbiology, Muscle, Neuroscience, Pancreatic Cancer, Prostate Cancer, Skin, Stem Cell, AKT Signaling, Angiogenesis, Articular Cartilage Extracellular Matrix, B Cell Markers, Basal Cell Marker, BBB VCAM-1 Signaling, Bladder Cancer, Cardiac Stem Cells, Colon Cancer, Colorectal Cancer, Complement System, CTLA-4 blockade immunotherapy, Cytokine Signaling, Defective Intrinsic Apoptosis, Dendritic Cell Marker, Digestion, Endothelial Cell Marker, Hematopoietic Stem Cells, Immune checkpoint, Infectious Disease, Lipid Metabolism, Lung Cancer, MAPK Signaling, Mast Cell Marker, Melanoma, Mesenchymal Stem Cell Differentiation, Mitochondria Marker, Neural Stem Cells, Neuroinflammation, Nuclear Marker, Oncology, Ovarian Cancer, PD-1 blockade immunotherapy, Signal Transduction, Stem Cell Differentiation, Transcription Factors

PECAM-1

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK